These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 25703752)

  • 1. End-of-Treatment-Response in patients treated for hepatitis C virus with standard interferon and ribavirin based on viral load.
    Rathore MA; Hussain AB; Ghani E
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):104-7. PubMed ID: 25703752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End of treatment response in chronic hepatitis C patients treated with interferon alpha and ribavirin.
    Tanveer A; Khalid SR; Kazmi SY; Faheem S
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):764-5. PubMed ID: 24112272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-ribavirin treatment in chronic hepatitis C--the less talked about aspects.
    Khalid SR; Khan AA; Alam A; Lak NH; Butt AK; Shafqat F; Alvi A; Ahmed I; Sarwar S; Niazi A
    J Ayub Med Coll Abbottabad; 2009; 21(2):99-102. PubMed ID: 20524481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment response in HCV related chronic hepatitis.
    Hussain AB; Hussain T; Anwar M; Hussain S; Kazmi Y; Tariq WU; Karamat KA
    J Coll Physicians Surg Pak; 2004 Aug; 14(8):466-9. PubMed ID: 15321035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to standard interferon A2b and ribavirin combination therapy in chronic hepatitis C treatment naive patients.
    Jadoon SM; Jadoon S; Muhammad I
    J Ayub Med Coll Abbottabad; 2010; 22(4):164-6. PubMed ID: 22455288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C.
    Salmerón J; De Rueda PM; Ruiz-Extremera A; Casado J; Huertas C; Bernal Mdel C; Rodríguez L; Palacios A
    Dig Dis Sci; 2006 May; 51(5):960-7. PubMed ID: 16758308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
    Gerner P; Hilbich J; Wenzl TG; Behrens R; Walther F; Kliemann G; Enninger A; Wirth S
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End treatment response and sustained viral response in hepatitis C virus genotype 3 among Pakistani population.
    Amir M; Rahman AS; Jamal Q; Siddiqui MA
    Ann Saudi Med; 2013; 33(6):555-8. PubMed ID: 24413858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
    Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A local experience of treatment response in chronic hepatitis C infection.
    Bijani B; Ghanei L; Kazemifar AM
    Infez Med; 2015 Dec; 23(4):343-8. PubMed ID: 26700085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment profile of hepatitis C patients - a comparison of interferon alpha 2a and 2b treatment regimes.
    Aziz S; Qamar R; Ahmed I; Imran K; Masroor M; Rajper J; Nafay S; Noorulain W; Khan MH
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):581-5. PubMed ID: 20810048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evolution of hepatitis C treatment: individualized therapy.
    Smith JR; Herrera JL
    Am J Gastroenterol; 2000 Sep; 95(9):2383. PubMed ID: 11007249
    [No Abstract]   [Full Text] [Related]  

  • 15. Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.
    Mirza S; Siddiqui AR; Hamid S; Umar M; Bashir S
    BMC Gastroenterol; 2012 Jun; 12():71. PubMed ID: 22697612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C--Swedish experts' meeting recommends combination treatment.
    Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerbor A; Uhnoo I; Weiland O; ;
    Scand J Infect Dis; 2000; 32(5):465-70. PubMed ID: 11055647
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficiency of enterosorbent White Coal in the treatment of the patients with chronic viral hepatitis C and its influence on lipoperoxidation markers and endogenous intoxication in blood of patients].
    Frolov VM; Sotskaia IaA; Kruglova OV
    Lik Sprava; 2012; (5):119-25. PubMed ID: 23534280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for hepatitis C infection.
    Liang TJ
    N Engl J Med; 1998 Nov; 339(21):1549-50. PubMed ID: 9819457
    [No Abstract]   [Full Text] [Related]  

  • 19. Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin.
    Khokhar N
    J Gastroenterol Hepatol; 2004 Apr; 19(4):471-2. PubMed ID: 15012792
    [No Abstract]   [Full Text] [Related]  

  • 20. Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK).
    Ahmad B; Ali S; Ali I; Azam S; Bashir S
    Virol J; 2012 Jan; 9():18. PubMed ID: 22244529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.